The impact of RAS mutation on the treatment strategy of colorectal cancer

Kirsten rat sarcoma (KRAS) is the most frequently mutated oncogene in colorectal cancer, being present in 30% of patients with localized disease and in almost half of the patients that develop metastatic disease. While the development of chemotherapy doublets and targeted therapy have improved survi...

Descripción completa

Detalles Bibliográficos
Autores principales: Pirvu, Edvina Elena, Severin, Emilia, Niţă, Irina, Toma, Ştefania Andreea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iuliu Hatieganu University of Medicine and Pharmacy 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9924809/
https://www.ncbi.nlm.nih.gov/pubmed/36818322
http://dx.doi.org/10.15386/mpr-2408

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9924809/
https://www.ncbi.nlm.nih.gov/pubmed/36818322
http://dx.doi.org/10.15386/mpr-2408

Ejemplares similares